Member Info for Notpotalot

“You can't go back and change the beginning, but you can start where you are and change the ending." – C.S. Lewis

Early in his tenure, Mark acknowledged mistakes had been made — and while he couldn’t rewrite the past, he could reshape the future. 17 months later, Val is reborn, with money in the bank, a rebuilt team, high calibre assets and a SH base that deserves success after years of one-way support.

A few resident historians cling to their preferred mythology, inventing a minimal cash runway because the real picture is too uncomfortable to accept: a cash runway to H2 even without R&D tax credits, additional Inaphaea income, grants or exercised warrants. This is also before the wave of RNS due over the coming weeks. Unlike those posting fiction, Mark has backed his conviction with his own money — now holding 7% of the company.

“What matters now is not where we’ve been, but where we’re going.”

Porky, unlike some holders, I still keep you around for the entertainment value. Calling Nick and other traders ‘muppets’ is certainly ….”creative”. 😀

Jaspal S and Stephen W dipping just under the 3% is nothing more than freeing up a couple of million to trade. There’s no great sell-off and no drama. Most of us aren’t brave enough to risk missing an RNS for the sake of a few hundred quid.

Get your 40 winks while you can. Many sleepless nights await over the next few months. 🥱

Pleasant dreams.

The asset/players: RNA Helicase Inhibitor — blocks the enzymes cancer cells rely on to grow and divide.

• McGill: global top 30 university, CA$750m research income, CA$2+Bn endowment, deep oncology infrastructure. • IRICoR: $100m+ R&D revenue, major grants, long term partner of €9Bn Ipsen. • ValiRx: – a £3m microcap with access to cutting-edge tech via Inaphaea and capability partners.

McGill provides the science, IRICoR drives commercialisation, external investors bring funding, and VAL simply leverages its existing assets.

Why VAL? - Big pharma is slow, expensive, and bureaucratic. Inaphaea can evaluate quickly, cheaply, and decisively. McGill doesn’t have a commercial lab, IRICoR doesn’t run wet lab evaluations, and big pharma won’t touch early stage assets. VAL is hungry, flexible, and built to operate exactly in this gap, without corporate drag.

The total RNA targeting small molecule market is projected at $ 5.5Bn by 2030. 1% of that is $55m. A tiny slice of a very large pie still tastes pretty good.

Nick , get over it – Mark Treharne is going nowhere. Mark E has spent 16 months assembling his Dream Team and I’m fairly sure the rants of a bitter ex-holder won’t cause either of them to lose any sleep whatsoever.

Funny how you have the gall to knock Twitter ramping when not long ago you threw your dummy out of the pram because your ‘followers’ dropped below 600 or so. 😂

Heartbreaking times for the perpetual doom merchants on here. Imagine spending the last 4 years posting day and night of Val’s demise …. only for the new CEO to stroll in, tidy up the mess, and transform the company in just 16 months.

Val is now positioned to excel with a glut of news imminent over the coming months. Many LT holders have savoured the progress and taken advantage of rock-bottom SPs to bring averages back into kilter. Funny how today’s reality keeps overruling the history lesson brigade. While some cut and paste merchants just recycle the same gloomy monologue, the company’s CEO and main shareholder watches in amusement as he finalises the first of a stream of RNSs.

It must be quite disconcerting. Imagine insisting the house is on fire and will need to be demolished, only for the fire brigade to show up, check the place over, and announce someone has simply burnt the toast. And now—just as the smoke clears—someone tidies a sofa cushion and finds yesterday’s winning lottery ticket.

A bit like how it feels being a Valirx holder under Mark’s regime.

“Intention is move top 10 forward rapidly in 2026 … milestone is to file key patents and partner the lead asset”.

Median upfront deal size for phase 2 assets up from $150m in 2024 to $775 in 2025. “…. our repurposing assets already have phase 1 clinical data”.

NB - This is a joint exercise with Dominion so on a $0.5 Bn deal, Valirx would only receive $250m. At least it would keep the wolves from the door. 😀

“I can see the traders walking this down now as they take their profits off the table”.

Lol, what Uncanny actually means: “please, please have a massive sell off so I can get back to my original holding.” 🤣

Accept it, you misjudged sentiment badly and now desperate to get back above 3%.

Look on the bright side, when news starts to flow shortly your remaining holding will be worth significantly more. 👍

@ Uncanny and UXM484

“You do realise your entire holding will be wiped out if the warrants do not get exercised in the coming months.“

As the main SH, so would CEO, Mark - the very man who is negotiating with major pharma and making all the key decisions.

He seems pretty chilled, don’t you both think? 😎 😉

MMs to increase the spread to 30%

Mark to release the overdue CLX patent update

Stellas and popcorn to watch the ensuing chaos

The SP has risen from 0.23p on NO updates PLUS traders have been taking their slice along the way. Pure sentiment so far but when the RNS’ start to flow, even traders will be reluctant to settle for a 20%-30% quick win.

Have a look at the IMM forum, late Aug. Just like Val now, page after page of wise-guys posting how crap the company is, “doomed, I tell ye, repent and sell out”. The SP was below 2p and in less than 3 weeks had increased 800%. That rise was based on its P140 drug, a new patent application and positive clinical trial findings.

Val will shortly be announcing more CytoLytix patent news with a ‘major pharma’ already interested. However, unlike IMM, Val has a further cluster of assets pending updates so whereas IMM couldn’t sustain the rise, Val has plenty of mileage in the RNS tank.

Actually Porky, I thought The Logical Song more appropriate for PP. 🤣

No issue at all , Stephen (Uncanny). Just traders making a few quid, with the aim of buying back in cheaper later.

Obviously a very dangerous game, particularly overnight as an early RNS could just be the spark we are waiting for.

Noticeable increase in Mark's Linkedin posts - is this leading up to an RNS?

GLA, DYOR

Anyone with any doubt regarding Val's potential, just look at the concerted effort by those trying to keep the SP down.

It ain't working and news hasn't even started to flow yet!

Having proved a couple of posters to be clowns, I’ll take some time out and won’t be back until the next decent RNS.

Probably see you all later this week! 🤡🤡 🤣

As expected, Ratcliffe also bottles it, just as Ray P did before him. Happy to post rubbish but unwilling (or unable) to support with hard cash. All talk regarding an imminent placing yet when given an opportunity to make an ‘easy’ killing, the excuses pour out. Another uninvested individual who gets some perverse pleasure out of knocking Val, simply for the fun of it.

As it stands, a few on here post rubbish at no cost to themselves – I gave them an opportunity to actually support their BS with their own money. As now proved, they don’t actually believe what they post. I’m under no illusions, I know it won’t stop them posting but at least it shows them up to be the keyboard warriors they are!

There you have it – Ray P has understandably backed out. Another who get their kicks knocking Val, yet doesn’t really believe their own B/S.

*“The company is doomed, definitely, last legs, no doubt about it. Err, what? bet on it? What real money you mean? Risk my piggy bank ?”(sorry Porky)

Yes, like a few other, you spent your days posting on a share you aren’t invested in and slagging it off for kicks.

*“Well, hang on. You have to admit, the Board never puts their own money in! I lost £100 here 15 years ago and still really pi55ed!”

Yes, so did a lot of punters, On the microcaps, timing is everything and most get it wrong (including me) – but for info, the CEO is now the largest SH, by a long margin and the company probably has the best prospects on the AIM.

Over to you then Rat. You asked if I am sincere – I am, certainly! As the multi-millionaire you purport to be, maybe something you can brag about later in the Gentlemen’s Club. Fancy risking some of your wealth for charity? Same bet. You can choose where we are to place our stake. Independent and agreed stakeholder, of course.

Personally, my guess is you couldn’t raise £1000 even if you sold all your comics but if you are genuine, a bit of petty cash is neither here nor there. Potentially £1100 to CRUK if I win, or £100 to top up the bar bill and laughing with the Lords at being proved right if you do. Come on, Sir! Show you actually believe your own BS!

Alternatively, admit you are a Sun reader, broke, on benefits and spend your days posting on Val, a share you would love to invest in – but the broker won’t accept stakes below £12.

Is the bet on, or have you too, bottled it? Are the cucumber sandwiches just a dream?

GLA, DYOR

Ray, I’m not generally a gambling man but at 10/1 I’m happy to put £100 down against your £1000. It is for a great cause, I’m sure you agree. The bet is that Val is still trading next May and, just for you a bonus, no SH dilutive funding before then. Porky reckons March, if we’re lucky. My £100 would go to CRUK anyway if I win. For you apparently, the easiest £100 you’ll ever make!

Anyway, are we on? You seemed so sure in your earlier posts. I’ll give you a few minutes to consider – you might need to change your undies!

If you decide, it’s a bridge too far, I understand and agree. Maybe bear that in mind in future when posting though. A few posters talk of Val’s history and its failings. No argument. It has been crap. However, new CEO, new philosophy, new assets, new patents, new team, new ideas. Give the company a chance – if still struggling in 6 months give it your full salvo.

Meanwhile….give Val a chance. You might be surprised, even amazed!

Ice, you’re talking as if Porky was a rational person.

He is a bitter ex Val holder, who sold out, put all his funds into 4D, ramped it to the hilt, then saw it go bankrupt – sucking in dozens of other gullible punters on the way.

Since then, 4 years of posting drivel at all times of the day and night. Yes, he called Val dilutions but has also predicted Val would go to the wall multiple times, just like his beloved 4D and Harland. Yet, here we are with funds, a glut of RNS due over the next 3 months and still no sign of 4D or Harl being reinstated.

You have to be genuinely concerned for his welfare over the coming months. A licencing deal would almost certainly tip him over the edge.

It is amazing how some companies attract negativity like a magnet. Val is such a share. While sometimes a negative poster may wish to make a valid observation, it is difficult to comprehend why some individuals would waste countless hours, and in some cases years and thousands of posts slagging off a share.

Below are listed some of the reasons why certain posters may display such negativity, though I’m sure there are more that might have been missed:

1) Shorting the stock – A valid reason if the poster believes the SP is destined to fall. A very dangerous game with Valirx though as with news due on so many fronts, the SP multi-bag within hours.

2) Trying to buy in lower – it could be the poster sees Val as a great opportunity but would like to see the SP a little lower before buying-in. Again, a dangerous game with so much potential for an explosive RNS.

3) Traders – The AIM is a natural habitat for this class of punter. Undoubtedly several traders have bought in here recently. Some will take a quick 50%, whereas others will wait for the 1.3p warrants to action. It is inevitable that traders will ramp or berate the share according to their position.

4) Boredom – With some individuals spending such a large part of their daily (and in some cases, nightly) lives repeating the same drivel, this has to be a distinct possibility.

5) Bitterness/ anger – As above, investors who have had their fingers burnt in the past may show their resentment by continual negative posts. Obviously, in doing this they seem to overlook that it was their own decision to invest at that time.

6) Jealousy – It may be that a poster has lost their funds elsewhere in a poor investment (eg 4D, Harland, FUM, etc) and while they see significant potential in Val, they simply have no funds left to invest.

7) Vindictiveness – in every aspect of life, there are unfortunately people who resent everyone and everything they encounter in life. The glass half-empty individuals. Instead of appreciating their health/blessings they exude negativity and spend their days lashing out at others.

8} Personality clashes – Maybe a negative poster has had clashes with an invested individual, not necessarily on the Val forum, and followed them here to stalk the latter.

9) The hero scenario – Finally, we come to those posters like Porky who pretend they are here to save others from Val when their own posts on other shares have cost gullible investors a fortune, enticing them into some of the worst investments ever to float in the UK.

If you qualify as one of those above, please feel free to tick those boxes applicable. I have to restrict to a maximum of 3 unfortunately, as some would clearly qualify on multiple counts.

Some factual posts there, Tradedesk.

Although your identity is irrelevant, Nick won’t like you highlighting his double standards.

Thank you. 😁